Nanette F. Santoro, MD

Despite the prevalence of GSM, the condition continues to be under-recognized and undertreated due to a combination of patient and provider factors. Providers need to take the initiative in screening and patient education.

Could menopausal hormone therapy protect some women's hearts, after all, as once thought? The new KEEPS trial aims to clarify that lingering question.

Quite often, the expectation of what is 'normal' leads patients to question their own gastrointestinal physiology.